. . . . . . . "[As evaluated by MTT assays, gefitinib (EGFR inhibitor) and DIM-C (PPAR? agonist) inhibited growth of 9 bladder cancer cell lines in a dose-dependent manner but with variable sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:35+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .